Literature DB >> 6561066

Inhibition of Lewis lung carcinoma in mice by local microwave hyperthermia combined with immunomodulating Propionibacterium granulosum KP-45.

S Szmigielski, S Zaboklicki, J Gil, J Jeljaszewicz, G Pulverer.   

Abstract

C-57 BL/6 mice with Lewis lung carcinoma were treated 2 weeks after tumor implantation with local microwave hyperthermia (2450 MHz, tumor temperature 43.5 degrees C, 30 min) and/or intratumoral or intraperitoneal injection of 1 mg cell walls of Propionibacterium granulosum KP-45. Tumor growth, survival time of the animals, and the delayed skin hypersensitivity to oxazolone were followed up, as well as the 3H-thymidine uptake of tumorous tissues and the number of lung metastases. The combined treatment of microwave hyperthermia with immunomodulating P. granulosum KP-45 resulted in significantly stronger inhibition of tumor growth than with each of these methods alone. The number of lung metastases could be significantly lowered, and the skin reactivity to oxazolone remained enhanced during the whole observation period (over 70 days after tumor implantation). The implications of the test observation are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6561066     DOI: 10.1007/bf00205421

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  14 in total

1.  Local microwave hyperthermia (43 degrees C) and stimulation of the macrophage and T-lymphocyte systems in treatment of Guerin epithelioma in rats.

Authors:  M Janiak; W Hryniewicz; J Jeljaszewicz; G Pulverer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26

2.  Tumor eradication in the rabbit by radiofrequency heating.

Authors:  J A Dickson; S A Shah; D Waggott; W B Whalley
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

Review 3.  The effects of hyperthermia in animal tumour systems.

Authors:  J A Dickson
Journal:  Recent Results Cancer Res       Date:  1977

4.  Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer.

Authors:  G L Asherson; W Ptak
Journal:  Immunology       Date:  1968-09       Impact factor: 7.397

5.  A lung-colony assay to determine the radiosensitivity of cells of a solid tumour.

Authors:  R P Hill; R S Bush
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1969-07

6.  Ultrasound, microwave and radiofrequency radiations: the basis for their potential in cancer therapy. Proceedings of the 10th L. H. Gray Conference. Oxford, 13-16 July 1981.

Authors: 
Journal:  Br J Cancer Suppl       Date:  1982-03

7.  Enhancement by Corynebacterium parvum of the normal and tumor tissue response to hyperthermia.

Authors:  M Urano; M Overgaard; H Suit; P Dunn; R Sedlacek
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

8.  Action of three species of Propionibacteria (P. granulosum, P. acnes, P. avidum) on experimental tumor systems in mice.

Authors:  W Roszkowski; M Kobus; M Luczak; H L Ko; S Szmigielski; B Laskowska; G Pulverer; J Jeljaszewicz
Journal:  Zentralbl Bakteriol A       Date:  1980-03

9.  Differences in cell surface antigens of tumor metastases and those of the local tumor.

Authors:  M Fogel; E Gorelik; S Segal; M Feldman
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

10.  Changes in cellularity induced by radiation in a solid tumour.

Authors:  C J Kovacs; H A Hopkins; M J Evans; W B Looney
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1976-08
View more
  2 in total

1.  Local microwave hyperthermia in treatment of advanced prostatic adenocarcinoma.

Authors:  S Szmigielski; H Zielinski; B Stawarz; J Gil; J Sobczynski; G Sokolska; J Jeljaszewicz; G Pulverer
Journal:  Urol Res       Date:  1988

2.  Effects and risks of radiofrequency ablation on the pulmonary tissue and vascular system: a preliminary histological study.

Authors:  Eiji Ogawa; Tatsuo Fukuse; Yoshinobu Toda; Hirokazu Kotani; Hiromi Wada; Toshiaki Manabe
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.